Friday, April 11, 2014

Global cancer immunotherapies market to reach $67.9 billion by 2018

Immunotherapy for cancers utilizes biological response modifiers or vaccines to enhance the endogenous immune response. Recent technological advances have made such therapies more efficacious than the standard treatments of surgery, radiation, and chemotherapy. Improving access to healthcare, increasing instances of cancer, and the entry of new therapeutic drugs will drive tremendous growth in this market for the foreseeable future.

BCC Research provides an in-depth analysis of the global market for cancer immunotherapies through its report, Cancer Immunology and Oncolytic Virology: Technologies and Global Markets. According to the report, this market was valued at $30.8 billion in 2012 and nearly $34.3 billion for 2013. BCC Research expects the market to grow to $67.9 billion by 2018, and register a five-year compound annual growth rate of 14.7% from 2013 to 2018.

RSS Feeds – Pharmaceuticals

Use this report to:
  • Gain an overview of the global market for cancer immunotherapies.
  • Analyze global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
  • Assess factors influencing market demand such as clinical guidelines, demographic changes, and market saturation.
  • Evaluate a technological discussion including the current state, newly issued patents, and pending applications.
  • Review company profiles of leading players in the industry.


To order your copy of this report (or any of its chapters) or to download the complimentary introduction chapter, click here.

No comments:

Post a Comment

Bookmark and Share